DCF — ATRIUM MEDICAL CENTER
Enterprise Value: $96.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$96.7M
Enterprise Value
$22.4M
PV of Cash Flows
$74.3M
PV of Terminal Value
$119.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $245.0M | $15.4M | 6.0% | $2.7M | $2.5M |
| Year 2 | $252.4M | $18.4M | 7.0% | $4.7M | $3.9M |
| Year 3 | $259.9M | $21.6M | 8.0% | $6.8M | $5.1M |
| Year 4 | $267.7M | $23.5M | 9.0% | $8.0M | $5.5M |
| Year 5 | $275.8M | $24.9M | 9.0% | $8.8M | $5.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $96.7M. Terminal value accounts for 77% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$237.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.05794871077644768
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5